Micron Technology (MU) Tops Q1 EPS by 1c, Q2 EPS Guidance Misses Consensus
Get Alerts MU Hot Sheet
Revenue Growth %: +345.7%
Financial Fact:
Total income before income taxes: -168M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Micron Technology (NASDAQ: MU) reported Q1 EPS of $0.48, $0.01 better than the analyst estimate of $0.47. Revenue for the quarter came in at $5.14 billion versus the consensus estimate of $5.01 billion.
"Micron posted solid first quarter results, delivering good profitability and positive free cash flow. With our strong execution and improving industry conditions, we are optimistic that Micron's fiscal second quarter will be the cyclical bottom for our financial performance," said Micron Technology President and CEO Sanjay Mehrotra. "Our significantly improved competitive position, dramatically stronger product portfolio, structurally higher profitability and investment-grade balance sheet position Micron very well to drive long-term shareholder value."
GUIDANCE:
Micron Technology sees Q2 2020 EPS of $0.35 at mid-point, versus the consensus of $0.41. Micron Technology sees Q2 2020 revenue of $4.5-4.8 billion, versus the consensus of $4.78 billion.
| FQ2-20 | GAAP (1) Outlook | Non-GAAP (2) Outlook |
| Revenue | $4.5 billion - $4.8 billion | $4.5 billion - $4.8 billion |
| Gross margin | 26% ± 1.5% | 27% ± 1.5% |
| Operating expenses | $878 million ± $25 million | $825 million ± $25 million |
| Interest (income) expense, net | $5 million | $0 million |
| Diluted earnings per share | $0.25 ± $0.06 | $0.35 ± $0.06 |
For earnings history and earnings-related data on Micron Technology (MU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share